Bibliography
- Zannad F , McMurrayJJV, KrumHet al. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. , 364, 11–21 (2011).
- Swedberg K , KomajdaM, BöhmMet al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet , 376, 875–885 (2010).
- Böhm M , SwedbergK, KomajdaM. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet, 376, 886–894 (2010).
- McAllister FA , WiebeN, EzekowitzJAet al. Meta-analysis: β-blocker dose, heart rate reduction, and death in patients with heart failure. Ann. Intern. Med. , 150, 784–794 (2009).
- Salpeter SS , OrmistonT, SalpeterE, PooleP, CatesC. Cardioselective β-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., 2, CD003566 (2002).
- Salpeter S , OrmistonT, SalpeterE. Cardioselective β-blockers for reversible airway disease. Cochrane Database Syst. Rev., 4, CD002992 (2002).
- Rutten FH . β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease. Future Cardiol., 7(1), 43–53 (2011).
- Inglis SC , ClarkRA, McAlisterFAet al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst. Rev. , 8, CD007228 (2010).
- Chaudhry SI , MatteraJA, CurtisJPet al. Telemonitoring in patients with heart failure. N. Engl. J. Med. , 363, 2301–2309 (2010).